Organization
Boston Univ, Boston, United States of America
1 abstract
Abstract
ABATACEPT IN EARLY DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS— RESULTS OF A PHASE 2 INVESTIGATOR-INITIATED, MULTICENTER, DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED TRIALOrg: University of Michigan, Ann Arbor, United States of America, Univ of Toronto, Toronto, Canada, Stanford Univ, Palo Alto, United States of America, UCL, London, United Kingdom, Univ of Minnesota, Minneapolis, United States of America,